ABSTRACT
A virulence factor denotes a bacterial product or strategy that contributes to virulence or pathogenicity. Streptococci produce a variety of protein toxins and enzymes that are capable of killing host cells and breaking down cell constituents, presumably to provide nutrients for the bacteria or to promote their spread. Some of these secreted products are hemolysins, streptokinases, hyaluronidases, exotoxins and proteases. In some cases, they play an important role in resistance to the host immune system, acting alone or in combination with cell-associated virulence factors (such as the capsule and surface proteins). Thus, the virulence of streptococci is considered as a multifactorial process. In contrast to well known human pathogens, and in spite of their veterinary importance, knowledge of virulence factors of most animal disease-associated streptococci is limited or almost inexistent. In the present article, the available information regarding the extracellular virulence factors of the most important animal diseaserelated streptococci is reviewed.
INTRODUCTION
The genus Streptococcus could be taxonomically divided into clusters or groups which included more than 30 species, as reviewed by Facklam (1). These are:
I. the pyogenic group, which includes several betahemolytic species, such as S. agalactiae, S. canis, S. dysgalactiae, S. equi, S. iniae, S. porcinus, and S. pyogenes. II. the bovis group, which includes S. bovis/S. equinus, S. gallolyticus and the new described species: S. infantarius, S. pasteurianus and S. lutetiensis. III. the salivarius group, which includes, S. salivarius, S. thermophilus, S. vestibularius, S. infantarius, S. alactolyticus, and S. hyointestinalis. IV. the mutans group, which includes S. mutans, S. cricetus, S. downei, S. sobrinus, S. ferus, S. macaccae, S. ratti, and S. hyovaginalis. V. the anginosus group (also referred to as the milleri group), which includes S. anginosus, S. constellatus, and S. intermedius. VI. the mitis group, which includes S. mitis, S. oralis, S. pneumoniae, S. cristatus, S. infantis, S. perois, and S. orisratti. VII. the sanguinus group, which includes S. sanguinis (formerly known as S. sanguis), S. parasanguinis, and S. gordonii.
The salivarius, mutans, anginosus, mitis, and sanguinus groups are all grouped in the major group of viridans Streptococcus species. Finally, the group of unusual Streptococcus species includes, among other species, S. uberis and S. parauberis (1). S. suis, an important swine pathogen, is not classified in any of the above mentioned groups or clusters. No single system of classification suffices for the differentiation of this heterogeneous group of organisms. Instead, classification depends on a combination of features including patterns of hemolysis observed on blood agar plates, antigenic composition, growth characteristics, biochemical reactions, and more recently, genetic analysis (1-3).
Several of these species are of exclusive importance in human medicine, whereas others are important agents of different animal diseases as well as zoonotic agents. The most important streptococci related to animal disease are S. suis, S. porcinus, S. dysgalactiae, S. agalactiae, S. uberis, S. equi, S. pneumoniae, S. canis, S. iniae, and S. gallolyticus. Most of these pathogenic streptococcal species possess a panel of virulence factors, including extracellular toxins or enzymes, surface associated proteins and adhesins and, in most cases, a capsule covering the bacterial surface. As for several other pathogens, virulence in streptococci could be considered as multifactorial. In this review, data about extracellular virulence factors of the most important streptococci associated with animal diseases will be summarized. The capsule, which is the most external layer of the bacterial surface, will also be considered under the definition of extracellular factors; as well as M-or M-like-proteins, that are fibrillar proteins largely exposed at the cell surface. In fact, M proteins are major virulence determinants and protective antigens of the human pathogen S. pyogenes. Besides several well known functions of M proteins (reviewed in reference (4)), wall-anchored M protein has recently been implicated in the maturation of a cysteine proteinase, which in turn releases biologically active fragments of M protein (5, 6) . In this regard, it could be considered an extracellular factor. Interestingly, several streptococcal species of Lancefield groups A, C and G streptococci express M-like proteins on their cell surface. Finally, even rare among Gram-positive species, surface fimbriae when present, will also be reviewed. The most common extracellular virulence factors present in streptococci associated with animal diseases are summarized in Table 1 .
STREPTOCOCCI OF PORCINE ORIGIN
In this section, the most important streptococcal species associated with diseases in pigs and of importance for the swine industry are described. unknown (present only in human TSLS isolates) two exotoxins described to date S. equi strangles-associated inflammatory activities SePE-I and SePE-H infection in humans is considered as an occupational disease with a probable underestimated importance (7) . S. suis isolates have also been recovered from ruminants, horses, wild boar, cats, dogs, and birds. This suggests that S. suis may be pathogenic for more than one animal species (9) (10) (11) .
S. suis possesses cell wall antigenic determinants related to Lancefield group D, although it is genetically unrelated to other members of this group. All strains are alpha-hemolytic on sheep blood agar, and many strains produce a beta-hemolysis on horse blood agar. S. suis can be classified into capsular types according to capsular polysaccharide antigens. The original classification of S. suis into Lancefield groups R, S, RS and T, which actually correspond to capsular types 2, 1, 1/2 and 15, respectively (12, 13) , is obsolete and should be avoided, since it was realized that the polysaccharides involved in serotyping originated from the capsular material rather than from the cell wall (13) . To date 35 capsular types have been described, and among them, capsular type 2 has always been considered as the most virulent and prevalent type isolated from diseased pigs in most countries where the swine industry is important (7) .
Knowledge on virulence factors and the pathogenesis of S. suis infection is still limited. S. suis is often transmitted via the respiratory route and remains localized in the palatine tonsils. Some animals will become healthy carriers and will never develop disease, whereas others will, sooner or later, develop bacteremia, sometimes septicemia, and finally meningitis. Hence, in these cases, bacteria gain access to the bloodstream, where they persist until they reach the central nervous system (14) . An early theory suggested uptake of bacteria by monocytes, intracellular survival and invasion of the central nervous system by the "Trojan horse theory" (15) . However, most studies carried out during the last decade suggest that bacteria may also use (an) other mechanism(s) to disseminate. A review on the recent proposed theories of S. suis pathogenesis was published in 2000 (14) . It has to be noted that most studies on S. suis virulence factors have been carried out with capsular type 2 strains. Although there is confusion in the definition of "virulence" for S. suis strains, researchers agree at least on one point: the existence of virulent and avirulent strains of S. suis type 2. To date, several proposed virulence factors have been described for S. suis type 2 strains. However, the mere presence of these virulence factors does not necessarily define a strain as virulent (14) .
Polysaccharide capsule
Encapsulated bacteria are responsible for causing some of the most serious invasive infections, including septicemia, pneumonia, and meningitis. The role of the capsule in bacterial virulence is to protect bacteria from the host's inflammatory response, i.e. complement activation and phagocyte-mediated killing (16) . S. suis possesses an integral, cell associated capsule (17) . The capsular polysaccharide (CPS) of S. suis type 2 is composed of five different sugars: rhamnose, galactose, glucose, N-acetyl glucosamine, and N-acetyl neuraminic acid (sialic acid) (18, 19) . The conformational structure of the capsule is largely unknown, although the sialic acid moiety has been suggested as being at a possible terminal sequence and probably responsible of antigenicity (19) (20) (21) . Even though antibodies against the type 2 CPS have been shown to have opsonizing activity, the CPS itself is a poor immunogenic material (22) . In addition, antibodies against the capsular material only partially protect against infection (21) and convalescent (protected) animals produce low levels of these antibodies (23) .
Despite the fact that the Trojan horse theory was largely addressed in the literature, findings suggesting that monocytes can phagocyte encapsulated S. suis cells in the absence of specific antiserum appears to be controversial (15) . Indeed, early studies suggested that pathogenic strains were able to resist phagocytosis in porcine or human blood in the absence of anti-S. suis specific antibodies. It was thought, therefore, that the capsule of the pathogenic strains was responsible for the resistance to phagocytosis, allowing pathogenic strains to become septicemic in pigs early in the infection, before an antibody response had been launched (24) . These observations were recently confirmed with the production of isogenic acapsular mutants from virulent S. suis type 2 strains. The absence of CPS correlated with increased hydrophobicity and phagocytosis rates by both murine and porcine phagocytes. In addition, unencapsulated mutants were shown to be avirulent in murine and pig models of infection (25, 26) .
Isolates of S. suis type 2 recovered from diseased animals were shown to possess a thicker capsule than those isolated from clinically healthy animals (27) . An increase of capsular material thickness following in vivo growth was noted for virulent strains but not for avirulent ones (28) . On the other hand, other reports do not demonstrate any correlation between the thickness of capsular material and virulence. Capsular type 2 is considered to be one of the most virulent serotype, but cells of the type reference strain were not covered by a thick layer of CPS, compared to other capsular types. It was suggested that the invasive ability of strains of this capsular type may be due to the composition of the capsular material which contains sialic acid (17) . This latter component has already been related to virulence for other bacterial agents of meningitis (29) . However, Charland et al. (30) further demonstrated that virulent and avirulent strains possess a capsule of similar size with similar concentrations of sialic acid. In fact, resistance to clearance from the bloodstream does not rely only on the presence of the CPS, since a well encapsulated avirulent strain is eliminated from the blood within 48 h, whereas a virulent strain can remain in relatively high numbers for more than five days (unpublished observations). In conclusion, despite the fact that the CPS seems to be a major virulence factor, most avirulent strains are encapsulated, indicating that other important virulence factors are essential.
Different strains within a single capsular type may vary in virulence and tropism, both within countries and among countries. There are also differences in pathogenicity among capsular types. Several capsular types are found mainly in healthy pigs, notably type 21 and to a lesser extent, types 17, 18, and 19 (31) . Correlation between capsular antigens and virulence is the basis for the suggestion that these antigens play a role in the pathogenesis of the disease (32) . However, this suggested correlation is not widely accepted. Indeed, some strains belonging to less common capsular types have been associated with severe cases of infection (unpublished observations).
Muramidase-released protein and extracellular protein factor
In addition to the CPS, cell-wall and extracellular proteins have been associated with virulence of S. suis. Two proteins, a muramidase-released protein (MRP) and an extracellular protein factor (EF), originally associated with virulent strains, have been reported in type 2 strains (33) . MRP is a 136-kDa cell wall-associated protein, which is also released during bacterial growth, whereas EF is a 110-kDa protein only detected in culture supernatants (33) . Type 2 strains with the phenotype MRP+EF+ induced severe clinical signs of disease, whereas strains with the phenotype MRP-EF-did not (34, 35 (36) (37) (38) . Strains of the last phenotype were isolated at high frequency from human patients, but caused almost no clinical signs of disease in experimentally infected pigs (36) .
Although the genes encoding the EF and MRP proteins have been cloned and characterized, the amino acid sequences did not provide information with respect to the possible functions of these proteins (36, 39) . One particular region within the MRP amino acid sequence, however, showed some similarity with the fibronectin (FN)-binding protein of Staphylococcus aureus, although binding of MRP to human FN could not be confirmed (39) . To date, the function of these two proteins in the pathogenesis of the S. suis infection remains unclear.
Isogenic mutants lacking both these proteins appeared to be as virulent as the wild type strain after experimental infection of newborn germfree piglets (40) . The authors suggested that the virulence of S. suis is a multifactorial process in which particular functions can be fulfilled by alternative factors. They also suggested that the synthesis of these proteins may only be coincidentally associated with virulence rather than being virulence factors per se. However, this association of MRP and EF with virulence is observed with strains from certain countries but not with others. For example, most North American strains isolated from acute cases of septicemia and/or meningitis (of either pig or human origin) were MRP and/or EF negative (38, 41) . Interestingly, as demonstrated by randomly amplified polymorphic DNA analysis, the few MRP+EF+ North American strains were clustered in the same group as European strains which shared the same phenotype (41) . Thus, the absence of one or more of these proteins cannot necessarily be associated with a lack of virulence. Again, since the term "virulence" is poorly defined for S. suis, it is also possible that, under standardised conditions, MRP+ EF+ strains are potentially more virulent than MRP-EF-strains.
Both MRP and EF proteins are major antigens recognized by convalescent sera of infected pigs (33) . A subunit vaccine containing MRP and EF protected pigs against challenge with a homologous or a heterologous MRP+ EF+ S. suis type 2 strain (42). The possible crossprotection of this type of vaccine would be of interest, since in addition to capsular type 2, strains of different types (from 1 to 22) from several European countries have been reported to produce MRP and/or EF (37, 43) . On the other hand, this kind of vaccine would not be useful in North America since, as previously mentioned, most virulent strains lack MRP and EF (38, 44) .
Hemolysin
Hemolysin activity is associated with virulence and pathogenicity of several bacterial species. A 54-kDa hemolysin, also known as suilysin, was identified in S. suis type 2 (45); subsequently a 65-kDa hemolysin from the same type was described (46) . These two proteins were shown to be the same toxin and the molecular mass variation was in fact related to purification methods (46) . Suilysin belongs to the family of toxins known as thiolactivated toxins, or more recently named as antigenically related cholesterol-binding cytolytic toxins. The most widely known members of this family are streptolysin O, listeriolysin, perfringolysin, and pneumolysin (47) . Suilysin possesses several characteristics in common with these toxins, such as loss of activity upon oxidation, reactivation upon reduction, inhibition by small amounts of cholesterol, formation of transmembrane pores and a "multi-hit" mechanism of action (46) . Membrane cholesterol is thought to be the toxin-binding site on the surface of eukaryotic cells (47, 48) . In addition, the Nterminal amino acid sequence of suilysin shows many similarities with the respective deduced sequences of the above mentioned toxins (45) . Furthermore, the gene encoding suilysin ( sly) has been sequenced, revealing a relative high similarity with the pneumolysin (49) .
While several of these cytolysins have been shown to be determinants of bacterial pathogenicity, their biological roles may vary, as do the lifestyles of the bacteria secreting them (47) . Despite the fact that a culture supernatant from a hemolysin-positive S. suis injected intraperitoneally failed to cause death in mice (50), a role of suilysin in virulence has been suggested since it has been shown to be cytotoxic to endothelial, epithelial and phagocytic cells (51-54). In addition, purified suilysin was shown to induce the release of several pro-inflammatory cytokines by human brain microvascular endothelial cells (55), by pig blood cells (unpublished observations), and by pig alveolar macrophages (56). It was also shown to induce the up-regulation of adhesion molecules on human monocytes (57). Thus, it may play an important role in bacterial dissemination and host inflammation, which is a hallmark of S. suis infections. Recently, a defined allelic-replacement mutant of the sly gene was shown to be nontoxic for murine macrophages cells, and thus further proves that the suilysin is probably the only cytolysin produced by S. suis (58). Despite its suilysin gene deletion, this mutant was still virulent in an intravenous pig model of infection. Since, total lesion scores were higher in pigs infected with the wild type strains than those infected with the mutant, it was suggested by the authors that suilysin may have a role in increasing the severity of clinical signs, and allowing bacterial colonization of infected organs to reach higher levels (58). Recently, an independent group also reported the production of suilysin knockout mutants (56). In vitro bactericidal test showed that both wild type and suilysin mutants were resistant to bactericidal factors in whole pig blood. Furthermore, in a model of experimental pig infection, either high or low doses of the mutant strains applied by aerosol to the pharynx induced disease similarly to the wild type strains. All diseased pigs showed fever, clinical signs and developed septicemia. S. suis was isolated from tissue samples such as brain, submandibular lymph node, lung, spleen, liver, heart or joint (56). Thus, the results of this study confirm that suilysin is not a critical virulence factor for S. suis serotype 2 infections.
Antibodies against the suilysin could not be detected in pigs experimentally infected with a suilysinpositive strain of S. suis type 2 (46); however, a vaccine containing purified suilysin was highly immunogenic and induced an increase in hemolytic-neutralising antibodies. This vaccine protected mice against a lethal S. suis type 2 challenge and induced protection against clinical signs in pigs (45, 59 ). Since several strains of different capsular types (from 1 to 22) and field isolates from diseased pigs were shown to have hemolytic activity (45, 50, 60) , suilysin was suggested as a promising cross-protection factor for use in vaccines (60). However, as observed for MRP and EF, most European strains are suilysin-positive, whereas variable production of this protein has been observed with North American strains (38, 61) . Indeed, the presence of the sly gene was demonstrated only in 7% of North America strains (49) . In a recent study in France, authors reported that most of the type 2 isolates recovered form diseased pigs carried MRP+EF-suilysin-phenotype. Thus, despite the fact that suilysin, EF and MRP are highly associated with pathogenicity, they should not be universally used to determine virulence of S. suis; and, as demonstrated by the use of knockout mutants, they cannot be considered as essential virulence factors (43, 56, 62, 63) .
Hyaluronidase
Hyaluronan is the main polysaccharidic component of the host connective tissues, thus the enzyme hyaluronidase, also called the spreading factor, is considered an important pathogenic factor for several hyaluronidase-producing streptococci. Hyaluronidase activity was reported once in the literature for some S. suis isolates (64), but the presence of this hydrolytic activity could not be confirmed by using either the S. suis type 2 reference strain or a representative strain of the North American phenotype (personal communication, Dr. D. Grenier, GREB, Université de Laval, Québec, Canada).
Thus, it is difficult to predict the possible prevalence of this enzyme among S. suis isolates.
Proteases
Proteolytic enzymes have been identified as important virulence factors in a number of microbial pathogens. Protease activity on casein has been detected in the culture supernatant of a S. suis strain isolated from a septicemia patient, however further studies on the identification of this activity were not reported (65). Recently, four major S. suis proteolytic activities (Argaminopeptidase, DPP IV, chymotrypsin-like and caseinase) have been reported and partially characterized (66). These activities were produced not only by some S. suis type 2 strains, but also by the reference strains of serotypes 1, 1/2 and 3. The Arg-aminopeptidase of S. suis was found to be both extracellular and cell-associated and showed a molecular mass of 55 kDa. It was suggested that the presence of this proteolytic activity would be useful in the production of ATP and other essential metabolic precursors. The DPP IV activity was found in the culture supernatant and on the cell surface of S. suis, having a molecular mass of 70 kDa. This activity is also present in mammals on activated T cells (CD26) and in a soluble form in plasma where it regulates bioactive peptides like cytokines (67). However, further studies are needed to evaluate the potential contribution of DPP IV in virulence of S. suis. The cell-associated caseinase activity, belonging to the class of metalloproteases, was detected in all tested strains of S. suis type 2. The protease responsible for this caseinase activity showed a molecular mass of 36 kDa and may have a nutritional function. In addition, it was suggested that it may participate in the maturation of bacterial protein precursors. However, further studies are needed to evaluate this hypothesis (66). The cell-associated chymotrypsin-like activity, belonging to the class of serine proteases, was detected in European ,but not in North American, strains of serotype 2 tested in this study. The authors suggested that these proteases may help S. suis to meet nutritional requirements, to neutralize the host defense system and to contribute to tissue invasion and destruction. Further analysis should be done to determine their physiological and pathological functions (66).
On the other hand, preliminary results indicate that S. suis type 2 does not produce IgG or IgA proteases, nor other hydrolytic activities, such as fibrinogen and fibronectin digestion, or phospholipase D activity. In contrast, the presence of phospholipase C activity was found (personal communication, Dr. D. Grenier, GREB, Université de Laval, Québec, Canada). Further studies should be done to determine the prevalence of this later activity, as well as its role in S. suis infection.
Superoxide dismutase
Superoxide dismutases convert superoxide anions to molecular oxygen and hydrogen peroxide, which, in turn, is metabolized by catalases and/or peroxidases. These enzymes constitute one of the major defense mechanisms of cells against oxidative stress and hence play a role in the pathogenesis of certain bacteria. The presence of a gene encoding superoxide dismutase (SOD), as well as SOD activity was reported in S. suis type 2 strains (2, 68). Superoxide is a major antibacterial substance in macrophage phagolysosomes, and thus the capacity to secrete this type of bacterial enzyme may be important in virulence. However, no correlation was observed between specific SOD activity and virulence. It is unlikely, therefore, that the production of this enzyme by S. suis would be related to phagocytic killing resistance of virulent isolates (68). Another report indicated that S. suis requires manganese, but not iron, for in vitro growth, and that manganese availability during growth affects the activity of the superoxide dismutase enzyme (69). Further studies are needed concerning the specific role of this enzyme in S. suis virulence.
Fimbriae
Fimbriae are important in bacterial adhesion to host surfaces; however, very few Gram-positive bacterial species have been shown to carry fimbriae, compared with the large number of Gram-negative species known to possess them (70). Interestingly, ultrastructural studies of surface components of S. suis revealed the presence of peritrichous, thin, and flexible fimbriae (17) . Morphologically similar fimbriae were observed on hemagglutinating as well as on non-hemagglutinating strains of S. suis (71). Thus the possible role of fimbriae in hemagglutination and/or cell adhesion remains unclear.
Bacteriocins
Bacteriocins are a heterogeneous group of antibacterial peptides characterized by their ability to inhibit other related or unrelated bacterial strains. Thus, they play a major role in the natural defense systems of several bacterial species (72). Since a number of bacterial species are found in the upper respiratory tract of pigs, the secretion of bacteriocins may be of competitive advantage for the producing strain. In fact, it was recently reported the production of bacteriocin-like substances by some isolates of S. suis type 2 (73). These substances, with molecular masses in the range of 14 to 30 kDa, were characterized as heat-stable and proteinase K, pronase, and elastase sensitive, but trypsin and chymotrypsin resistant. Maximum production was reported during the mid-log phase of bacterial growth and the bacteriocins were active against other S. suis isolates and other swine pathogens. Only 4 of 38 S. suis strains tested produced a bacteriocin, and three of them were originally isolated from healthy carrier pigs (73). However, the role of bacteriocins in S. suis infection is still unclear.
Streptococcus porcinus
S. porcinus strains belong to serological groups E, P, U, or V, and are widely distributed in animals. S. porcinus group E is mainly associated with disease in pigs, and it is the etiological agent of the streptococcal lymphadenitis of swine, an important disease also known as jowl abscess, cervical lymphadenitis, feeder boils, or swine strangles. SLS is a problem for the swine industry, because of the losses from trimming and condemnation of infected carcasses. S. porcinus strains do not appear to be the primary cause of any other important disease or condition (74, 75). Among strains of group E, several serotypes have been described (II, IV, V, VI, VII, VIII), with type IV most commonly isolated from swine lymphadenitis (74, 75). S. porcinus is rarely reported from human infections. In these rare cases, the majority of the isolates were recovered from the genitourinary tract of reproductive-age female patients, some being associated with complications of pregnancy and delivery problems (76) . Whether these isolates are significant pathogens is unknown because very little clinical information is available to date.
S. porcinus enters the swine host through the mucosa of the pharyngeal or tonsillar surfaces, and are carried to the lymph nodes, primarily of the head and neck region, where abscesses are formed. There is little effect upon the overall state of health of the animal, but the finding of such abscesses at slaughter is a cause for condemnation of the head or, occasionally, the entire carcass. Cell wall antigens induce the formation of serum agglutinins; a microtitration agglutination test, based upon reactions involving the type IV antigen, is considered a reliable test for detection of infection in animals. Antigenic components include group and type antigens, extracellular enzymes, and an antiphagocytic factor (APF) which may be associated with virulence of the organism and with protective immunity (74).
The APF was described as a surface protein with morphological characteristics of fimbriae and considered to be analogous to the M-protein (also named for this reason as the group E streptococcal M protein). It develops on cells cultured in vivo or in media fortified with serum, and it was suggested to render the bacterial cells resistant to phagocytosis by porcine leukocytes (for a review see reference (74)). On the other hand, there are conflicting data regarding the formation of capsules. Freshly isolated organisms from cervical abscesses were reported to be encapsulated but capsule disappeared upon in vitro passages, although some nutritional conditions could induce its formation (74). The contribution of the capsule to phagocytosis resistant is so far unknown.
In general, group E streptococci are not considered to be strongly proteolytic (74) and this observation may be extended to S. porcinus. Although a streptokinase has been described with an apparent specificity for swine plasminogen, its role in S. porcinus virulence is so far unknown. Streptokinases of other streptococcal species have been shown to be important plasminogen activators, and thus contribute to tissue damage and bacterial spread across tissue barriers, as described below (77, 78) . Only a low number of isolates show neuraminidase activity, but no hyaluronidase activity has been detected so far (64, 74). The presence of a gene encoding for a manganese-dependent SOD has been reported (2); however, no further information is available with respect to the possible role of this enzyme in S. porcinus virulence.
Concerning the presence of toxins, a CAMP-like reaction was reported among several isolates of S. porcinus. As discussed below; this reaction is mediated by an extracellular protein, also named as co-hemolysin, in several streptococcal species. However, the putative toxin or co-hemolysin of S. porcinus involved in this reaction has not been characterized (64, 75). Although this bacterium shows beta-hemolysis on blood agar, to date, no hemolysin has been described.
Streptococcus dysgalactiae subsp. equisimilis
The species S. dysgalactiae was originally proposed to accommodate a heterogeneous group of streptococci associated with infections in animals and human beings. This taxon includes now animal isolates of alpha-hemolytic group C streptococci, previously called S. dysgalactiae; animal and human isolates of beta-hemolytic group C streptococci, previously called ' S. equisimilis'; beta-hemolytic group L strains associated with infections in animals and, rarely, in humans; and beta-hemolytic group G strains isolated from humans. The exact composition of the taxon S. dysgalactiae has been in a state of flux for the past few years till the separation of this group of strains into two subspecies, S. dysgalactiae subsp. dysgalactiae and S. dysgalactiae subsp. equisimilis. Strains of the first supspecies group belong to Lancefield group C and are not beta-hemolytic, while the second subspecies group includes strains of Lancefield group C, L and G, as well as recently reported group A strains, which are beta-hemolytic and commonly isolated from human infections. It is important to state that both subspecies possess virulence factors similar to those found in S. pyogenes, including M proteins (1).
S. dysgalactiae subsp. equisimilis (which will be referred throughout the text as S. equisimilis ) is an important pathogen for horses and pigs. Beta-hemolytic S. equisimilis of group C and L are associated with endocarditis, arthritis and lymphadenitis in pigs. These isolates are reported as CAMPnegative, but hyluronidase positive (64, 79). Some animal isolates of S. equisimilis were shown to produce bacteriocinlike substances (80) . This activity could be of selective advantage since this bacterium is present as part of the normal flora of pigs (64). The latter activity, however, has not been further characterized. Indeed, little information is available regarding the virulence factors of animal isolates of S. equisimilis. This is in contrast with the greater information about human isolates. In this regard, high hemolytic variants have been reported among human clinical isolates of S. equisimilis. These variants were associated to clinical symptoms of pharyngitis and to the development of serious streptococcal sequelae (81) . The hemolysin, which can be neutralized by adding cholesterol, was purified and characterized as a streptolysin O secreted toxin (82) . Despite the fact that S. equisimilis strains of animal origin are reported as beta-hemolytic, no hemolysin has been characterized to date. In addition, the presence of M-like proteins and a superantigen-like gene homologous to the gene speG of S. pyogenes have been reported for human isolates of S. equisimilis (83, 84) , although no further characterization of this exotoxin is available in the literature. The presence of exotoxins or M-like proteins in isolates of animal origin has not been reported so far.
Group C S. equisimilis isolates from non-human hosts have been regarded as non-streptokinase producers simply on the basis of the inability to activate human plasminogen. However, it was demonstrated that group C streptococci isolated from non human sources secrete streptokinases which preferentially activated plasminogen obtained from the host from which the isolate had been obtained (85) . However, they all bound plasminogen regardless of the host source. These observations suggested that there are two major events in the activation of plasminogen by streptokinases; a primary event (binding) which is not species specific and a secondary event (activation) which is species-specific (86) . It has been suggested that species-specific plasminogen activation may account for the species preference of certain streptococci (85) . In this regard, S. equisimilis isolates from equine origin were shown to specifically activate equine plasminogen, while isolates from swine origin activate porcine plasminogen, with trace activity for human plasminogen. S. equisimilis not only produces a plasminogen activator but also binds the generated plasmin, thus providing the bacteria with unregulated proteolytic activity and enhanced invasive properties (85) . The streptokinase genes from S. equisimilis strains of different origins have been cloned and characterized. The streptokinase secreted by equine isolates, which was purified as a protein of 49 kDa, has little sequence or amino-acid similarities to any known streptokinases secreted by either human or porcine isolates (86-88). The streptokinase secreted by porcine isolates has limited structural and functional similarities to streptokinases secreted by human isolates (86) . The epidemiological associations between streptokinase activity and the species of mammal subject to infection have suggested a possible cause-and-effect relationship.
STREPTOCOCCI OF BOVINE ORIGIN AND ASSOCIATED WITH MASTITIS
Mastitis is an inflammatory disease of the mammary gland and is one of the most significant limiting factors to profitable dairying throughout the world. Several bacterial genera and species capable of causing mastitis are widespread in the environmental of dairy cows. Mastitis organisms have been categorized as contagious or environmental pathogens based on their distinct characteristicts of distribution and interaction with the teat and teat duct. Contagious pathogens, such as S. agalactiae, live and multiply on and in the cow's mammary gland and are spread from animal to animal primarily during milking. Environmental pathogens, such as S. dysgalactiae and S. uberis, are those whose primary reservoir is the environment where cows live (89, 90) .
Streptococcus dysgalactiae subsp. dysgalactiae
S. dysgalactiae subsp. dysgalactiae (which will be referred throughout the text as S. dysgalactiae) is one of the most common pathogens of bovine mastitis and causes large economic losses in the dairy industry. It is capable of survival in the mouth, vagina, and skin of healthy animals as well as bedding and pastures. Because of its environmental location, normal hygiene methods and antibiotic therapy are less effective in preventing S. dysgalactiae infections than infections with other contagious pathogens (89, 90) . Isolation of this bacterium from human infections has not been documented (1). In spite of its high prevalence, little is known about factors that contribute to the virulence of S. dysgalactiae. The bacterium expresses several cell-associated and extracellular factors; yet, the relative importance of these factors in the transmission and pathogenesis of mastitis caused by S. dysgalactiae has not been defined. S. dysgalactiae can interact with several plasma and extracellular host-derived proteins such as immunoglobulin G, albumin, fibronectin, fibrinogen, collagen, vitronectin, plasminogen, and alpha 2-macroglobulin. These interactions are mediated by bacterial surface proteins. In addition, S. dysgalactiae adheres to and is internalized by bovine mammary epithelial cells in vitro. These aspects will not be discussed here (for a review see reference (90)). On the other hand, this organism also produces extracellular enzymes which may be involved in promoting dissemination of the organism into host tissue, as discussed below.
Capsule
Presence of capsule was detected in only some fresh isolates from intramammary infections; however, capsule expression was lost upon storage. Attempts to induce in vitro capsule expression in S. dysgalactiae strains using supplemented media were unsuccessful. As discussed below, expression of capsule in S. uberis, another important mastitis pathogen, has been associated with resistance to phagocytosis by bovine mammary gland macrophages. In this regard, a hydrophilic strain of S. dysgalactiae was significantly more resistant to phagocytosis by bovine mammary gland macrophages than a hydrophobic strain. The contribution of the capsule to these two phenotypes was not specified (91) . Thus, further studies are needed to determine conditions for capsule expression by S. dysgalactiae, as well as its role in virulence (90).
M-like proteins
The M proteins have for a long time been considered one of the major virulence factors of S. pyogenes by mediating resistance to phagocytosis. Although not a prerequisite for inhibition of phagocytosis, fibrinogen (Fg) and IgG binding is a common feature among these proteins (4, 92). Fg binding is common among mastitis isolates of S. dysgalactiae (93, 94) . Indeed, a gene called demA, encoding for a protein (DemA) with a molecular mass of ~58 kDa, was characterized. DemA displays both plasma protein binding properties and sequence similarities with the M and M-like proteins of other streptococcal species. In competitive binding assays, purified recombinant DemA protein was found to completely inhibit Fg-binding to S. dysgalactiae (95) . A gene similar to demA was isolated from another strain of S. dysgalactiae and named demB. Directly upstream of the respective dem genes, two other genes, called dmgA and dmgB, were described. The proteins encoded by these genes show similarities to Mga proteins in S. pyogenes which are known to be involved in the regulation of the expression of various virulence factors (92) . Thus, it was suggested that the dmg and dem genes are members of a regulon similar to the described mga regulon in S. pyogenes. The presence of demA and dmg-like genes in several mastitis isolates of S. dysgalactiae suggests that the encoded proteins are of importance for the virulence of this species (95) . Fg binding by S. dysgalactiae has been related to inhibitory effects of phagocytic killing by neutrophils in a similar manner as M protein carrying S. pyogenes isolates from human infections (96).
Fibrinolysin and streptokinase-like activity
S. dysgalactiae produces a fibrinolysin specific for bovine but not for human fibrin. Fibrinolysin activity was due to a proteolytic enzyme rather than to streptokinase-like activity (90, 97) . On the other hand, the ability of this bacterium to activate mammalian plasminogen and to bind either plasmin or its zymogen was reported (98) . Activation of bovine plasminogen was dependent on both the strain and the growth medium used for cultivation. Several strains were able to activate bovine and ovine plasminogen and some of these also activated plasminogen from horse, rabbit and pig origins, but none activated human plasminogen. S. dysgalactiae is also capable of binding plasmin and plasminogen with an apparent preference for bovine plasmin. It was suggested that the activation of plasminogen and the binding of plasmin by bacteria may have many effects which promote infection (98).
Other putative virulence factors
Extracellular hyaluronidase has been isolated and purified from S. dysgalactiae as a protein of approximately 55 kDa. However, the importance of this protein has not been evaluated (99) . Since hyaluronic acid is an important intercellular component, a possible role of bacterial hyaluronidases in tissue invasion has been proposed for other streptococci (see below). In addition, S. dysgalactiae has been shown to posses a gene that encodes a manganesedependent SOD (2), as well as to produce a bacteriocin-like activity (80) . No further characterization of these factors was reported and their putative role in virulence is so far unknown. As mentioned above, the production of a bacteriocin may give the producing strains a competitive advantage by killing bacteria in the same environment. Finally, a mitogenic substance (superantigen), designated S. dysgalactiae-derived mitogen (SDM), has recently been purified from the ATCC43078 strain. The sdm gene consists of two segments encoding a signal peptide and a mature 25 kDa protein. Three out of 34 animal isolates of S. dysgalactiae tested showed mitogenic activity and were positive for sdm. Further investigations are required to determine the pathogenic role of SDM in animal infections caused by this bacterial species (100).
Streptococcus uberis
S. uberis is the causative agent of a significant proportion of clinical episodes of bovine mastitis worldwide. In the United Kingdom, it may be responsible for as many as 33% of all clinical cases of bovine mastitis (101), and in Denmark, 23% of the mastitis cases in dairy herds could be related to an infection by S. uberis (102). Pathologic findings of experimentally induced S. uberis infection in the mammary gland of cows revealed acute inflammatory response involving accumulation of large numbers of neutrophils in the secretory acini followed by infiltration of septa by lymphocytes, septal edema, extensive vacuolation of secretory cells, focal necrosis of alveoli, small outgrowths of the secretory and ductular epithelium, and widespread hypertrophy of the ductular epithelium. Streptococci are found phagocytosed inside macrophages in several types of affected tissues, highlighting the importance of the macrophage as the primary phagocytic cell. In fact, the value of the exuberant neutrophil response by the host in defense of the gland has been questioned (103).
It has been suggested that for intramammary infections to occur, bacteria need mechanisms associated with avoidance of phagocytic defenses, rapid growth, adherence to epithelial cells, and/or colonization of mammary tissue (104). During the last decade, several potential virulence factors of S. uberis have been identified and previously reviewed (101, 104). Some of these factors are cell-associated while others are extracellular. Proposed antiphagocytic factors of S. uberis include capsule, neutrophil toxin, M-like and R-like proteins. Potential virulence factors produced by S. uberis and released extracellularly include hyaluronic acid capsule, hyaluronidase, plasminogen activator or streptokinase, and Uberis (CAMP) factor.
Hyaluronic acid capsule
Phagocytosis and killing of bacteria by neutrophils constitute major defense mechanisms of the lactating mammary gland. This system is responsible for controlling other infections within the bovine udder, such as that produced by Staphylococcus aureus. The role of phagocytes is less clear with regard to S. uberis infections. However, strains of S. uberis that resist phagocytic killing in vitro can establish infection more effectively than susceptible strains (105, 106). The ability of certain strains of S. uberis to resist the bactericidal action of neutrophils has been reproduced in vitro when the organism is grown in the presence of casein-derived peptides (107). Indeed, the production of a hyaluronic acid containing capsule was correlated with the ability to resist in vitro phagocytic killing by neutrophils (107-109). Researchers recently identified the genes responsible for capsule formation in S. uberis which are placed in a novel genomic arrangement compared to that observed in S. pyogenes (110). The hyaluronic acid capsular operon in S. pyogenes includes three genes: hyaluronate synthase ( hasA); UDP-glucose dehydrogenase ( hasB); and UDP-glucose pyrophosphorylase (hasC), with only hasA and hasB being essential for capsule production (111). However, the S. pyogenes hasABC capsular operon structure is not conserved in S. uberis, and two discrete loci comprising homologues of either hasAB or hasC were instead identified. Disruption of S. uberis hasA or hasC resulted in complete cessation of hyaluronic acid capsule production. Correspondingly, these mutants were found to have lost their resistance to in vitro killing by bovine neutrophils (110).
Most studies have been done with neutrophils; however, the importance of macrophages as the primary phagocytic cell has been highlighted (103). In this regard, studies of interaction of S. uberis with bovine mammary macrophages revealed that encapsulated strains are "to some extent" ingested and killed by macrophages; however, phagocytic and killing rates of non-encapsulated strains are considerably higher than those observed with encapsulated strains (112). Opsonization of encapsulated strains with homologous or heterologous antiserum increases the phagocytic and killing rates (112, 113). On the other hand, differences in interactions between S. uberis and either neutrophils or macrophages have been reported and showed that macrophages isolated from mammary secretions collected during the mid-dry period are capable of engulfing and killing strains known to be either resistant or susceptible to phagocytic killing by neutrophils, in the presence of serum and skimmed milk (114). Complement does not seem to influence the opsonization of S. uberis while both, IgG1 and IgG2 isotypes, were shown to opsonize both types of strains. However, bacteria were not killed in the absence of opsonin (114). Differences in expression and distribution of Fc receptors would be responsible for such distinct pattern of phagocytosis observed between the two cell types (114).
The precise mechanism by which the capsule layer confers in vitro resistance to phagocytosis and/or resistance to intracellular killing remains unclear. In fact, the use of the "bactericidal test or phagocytic killing assays" does not allow to differentiate between intracellular or extracellular bacteria (specially in the above mentioned studies with neutrophils), thus it is difficult to predict the role of the S. uberis capsule in resistance to phagocytic uptake or in resistance to intracellular killing (if the bacterium is phagocytosed). Indeed, the importance of the capsule as a virulence factor during in vivo infection has been recently questioned (115). In fact, both clinical and environmental isolates posses hasABC genes (115); and differences in the ability to cause clinical mastitis and in phagocytic killing resistance do exist among encapsulated strains, suggesting that other virulence factors are also essential (106). Furthermore, a capsular mutant strain induced inflammatory responses and milk bacterial shedding similar to those observed with the wild type strain in an experimental model of bovine mastitis. It was suggested that the acapsular mutant strain is able to withstand the bactericidal action of incoming neutrophils, since it persisted in the mammary gland despite the presence of a overwhelming neutrophil response (115). This is in marked contrast to the sensibility of this mutant strain to bovine neutrophil killing reported previously in bactericidal studies conducted in vitro (110). Since reversion of the mutant sensibility to neutrophil killing in vitro could be obtained by pre-growing of the mutant in raw skim milk, which more closely mimic the situation in vivo, it was suggested that the capsule may not be the sole effector of resistance to neutrophil killing. This also raises the possibility of the concomitant expression of additional cell surface-associated proteins that could influence the interaction of the bacterium with phagocytes (110). In this regard, it was suggested that the resistance of encapsulated S. uberis to neutrophil killing was due to a proteaseresistant molecule of 500-1000 Da that could inhibit or lyse neutrophils. Such a molecule, named the "neutrophil toxin", appeared to be produced by encapsulated strains and it would be retained in the capsular matrix (104). On the other hand, an "additional hypothesized antiphagocytic component" was recently suggested, since supernatants of bacterial cultures in milk were shown to prevent the bactericidal action of neutrophils (115). The nature and precise mode of action of these inhibitory activities (if they are different) are yet to be established.
M-like protein
Reports indicating the presence of a M-like protein in strains of S. uberis, screened by using antibodies against the type 24 M protein of S. pyogenes, have been previously reviewed (104). Since the M-like protein of S. uberis has been suggested to have a role in bacterial adherence to and invasion into bovine mammary epithelial cells, it could be an important factor in the pathogenesis of S. uberis infection.
Streptokinases
Discrepances in streptokinase gene and protein nomenclature in the literature are extremely confusing. A plasminogen activator (streptokinase) from S. uberis, with activity towards bovine, equine and ovine plasminogen, but not human or porcine ones was described and purified (116, 117). This activity was related to a protein of 29 kDa, which could also be found as a dimer of 57 kDa. This protein was later reported by the same group as having a molecular weight of 32 kDa and as being different to the above described streptokinase of S. equisimilis (118). The gene encoding the plasminogen activator was cloned and characterized by two independent groups (119, 120), and named as pauA or skc, respectively. The pauA nomenclature will be retained in this review. The pauA gene encodes for a protein of 33.4 kDa, consisting of 286 amino acids including a signal peptide of 25 amino acids, and it seems to be highly conserved within the species. The protein was named as PauA (but also found in the literature as SUPA or SKu), and shows only weak amino acid sequence homology to the streptokinases isolated from S. equisimilis and S. pyogenes; and no significant genomic homology to any member of the streptokinase family of plasminogen activators. PauA has been considered a new class of bacterial plasminogen activator that may act through a unique mechanism (119-122). In the course of cloning pauA, a single isolate (SK880) from a panel of 11 strains tested was reported to display plasminogen-dependent fibrinolysis due to a plasminogen activator of 45 kDa (119). This molecule failed to cross-react with antibody raised to PauA, suggesting that significant differences between the two S. uberis plasminogen activators exist. This second plasminogen activator was named PauB and shown to display an unexpectedly broad specificity profile for bovine, ovine, equine, caprine, porcine, rabbit, and human plasminogen. Clinical and nonclinical field isolates from United Kingdom or Danish herds were screened for the pauB gene and none were identified as carrying it. Therefore, PauB represents a novel but rare bacterial plasminogen activator which displays very broad specificity (123).
By activation of plasminogen to plasmin through the action of its plasminogen activator, S. uberis was also shown to be able to acquire surface-localized plasmin activity (124). For a mastitis-inducing pathogen, the production of a plasminogen activator could be of importance in two ways. In addition to the generation of plasmin activity needed for degradation of extracellular matrix proteins and subsequent colonization, the activation of endogenous plasminogen present in milk would lead to hydrolysis of milk proteins and, thereby, liberation of peptides from which a nutritionally fastidious microorganisms such as S. uberis could obtain essential amino acids and colonize environments such as the bovine mammary gland (125).
Hyaluronidase
An early study reported the production of free hyaluronidase by S. uberis. The purified hyaluronidase has a molecular weight of approximately 54 kDa (126). It was suggested that the presence of this enzyme could facilitate bacterial dissemination into the mucosal barrier and other tissues leading to spreading infection (104). As shown with hyaluronic acid capsule, S. uberis hyaluronidase also influence mammary epithelial cell proliferation in vitro, which could have important consequences in vivo during the periparturient period, when mammary tissue undergoes rapid differentiation and growth (127). In addition, hyaluronidase would be responsible of the release of soluble capsular hyaluronidate, which may affect phagocytic capabilities and block surface receptors of phagocytic cells (108).
CAMP-factor
The CAMP reaction is a synergistic lysis of erythrocytes by the interaction of an extracellular protein, named as co-hemolysin or CAMP factor, produced by some streptococcal species with the Staphylococcus aureus sphingomyelinase C (beta-toxin). It has been reported that some cultures of S. uberis present CAMP-like synergistic hemolytic activities on sheep blood agar (128). The cohemolytic (CAMP) factor was partially characterized and named as Uberis-factor. It was shown to share similar properties with the S. agalactiae CAMP-factor. The Uberis-factor was initially reported as a protein of 42 kDa (129). However, the gene coding for the Uberis-factor (cfu) from S. uberis has now been cloned and the gene product has been shown to be a protein of 28 kDa. The deduced amino acid sequence is highly homologous to the corresponding S. agalactiae CAMP factor (130, 131). The Uberis-factor has been shown to exert lethal effects when administered parenterally to rabbits and white mice (132). Thus it may represent a significant component within the complex of pathogenic factors of this bacterium. However, the role of this activity in the pathogenesis of bovine mastitis has not been established; neither the production of Uberis-factor not the presence of the cfu gene has been correlated to virulence of individual strains (101).
Other putative virulence factors
Several reports showed adherence and/or invasion of S. uberis to bovine mammary epithelial cells in culture. Proteins induced or having increased expression in both supernatant and surface-associated samples from S. uberis co-cultured with mammary epithelial cells have been suggested to be regulated during in vivo infection (133, 134). Some of these proteins were recognized by antibodies in serum obtained from a convalescent cow. In supernatant samples, two distinct protein bands at 35 and 36.8 kDa were identified. These two bands were absent when bacterial protein synthesis was inhibited by chloramphenicol. The identity and function of these secreted proteins are unknown (133). In addition, the possible mechanisms of adhesion, invasion and interaction of this bacterial species with host cells and extracellular matrix proteins have been previously reviewed (101, 104) and are out of the scope of the present review.
Streptococcus agalactiae
S. agalactiae or Group B Streptococcus (GBS) is a common cause of sepsis and meningitis in newborns, and causes disease in pregnant women and non-pregnant adults. The incidence of disease among non-pregnant adults, particularly those with underlying conditions, is increasing. In addition, many individuals are asymptomatically colonized with GBS. Epidemiological aspects of human infections, as well as phenotypic and genotypic characteristics were recently reviewed (135). In addition, an extensive review of the pathogenesis and virulence factors involved in humans infections was reported (136) .
From a veterinary point of view, this bacterium is considered one of the major causes of bovine intramammary infections, particularly in North America, and a source of economic loss for the industry. Infection with S. agalactiae is associated with elevated somatic cell and total bacteria counts and a decrease in the quantity and quality of milk products produced (137) . In addition, S. agalactiae could be responsible for meningitis in fish, and was also isolated from pathological processes in various other animal species, indicating that this bacterium has a broad host range (138) (139) (140) (141) . However, less information is available regarding the pathogenesis of animal infections caused by GBS, specially the virulence factors which may be involved. Interestingly, in a comparative study in experimental mouse models, it was shown that lethality and levels of colonization in spleens or livers were significantly greater for human isolates than for bovine isolates. However, no statistically significant differences in the ability to colonize placentas and in the induction of abortions were noted between isolates of either origin (142) . On the other hand, human and bovine GBS isolates were characterized as two distinct populations (143), although isolates from other animal species behaved similarly to those from humans, regarding cultural, biochemical, serological and bacteriocin sensitivity properties (141).
Polysaccharide capsule
GBS strains associated with disease are almost invariably encapsulated (144 The CPS is well established as a critical virulence factor which protects bacteria against the immune response of the host. However, studies on GBS phagocytosis are somehow controversial. Despite that the CPS was described as an antiphagocytic factor (29), it has been lately shown that well encapsulated GBS serotype III strains are easily ingested by murine macrophages under non-opsonic conditions (146) . The CPS would rather protect bacteria against intracellular killing by modulation of opsonin deposition on the bacterial surface. With minor exceptions, the various GBS CPS antigens are composed of the same four component monosaccharides: glucose, galactose, Nacetylglucosamine and sialic acid. The biochemistry and immunology of GBS capsular polysaccharide has been studied most thoroughly in serotype III organisms, and this, in the context of human infections. The native type III CPS is a highmolecular-weight polymer composed of more than 100 repeating pentasaccharide units. Sialic acid is known to be a critical element in the epitope of type III GBS capsule which confers protective immunity (29, 136) . In addition, direct evidence for the role of type III GBS capsule in virulence is provided by the construction of isogenic capsule-deficient mutants. These mutants were shown to be significantly less virulent in animal models of GBS infection (29, 147) .
As it is the case with most other pathogenic bacteria, effective elimination of GBS by neutrophils and macrophages requires opsonization. Without the participation of specific antibodies and serum complement, phagocytic killing of GBS is dramatically reduced (136) . The presence of naturally acquired antibodies against S. agalactiae was reported in normal bovine serum (NBS), while levels of antibodies in milk wheys were lower than in sera, and pre-colostral calf serum (PCS) was shown to lack antibodies to type II and III S. agalactiae. Antibodies present in NBS were required for the efficient ingestion of both human and bovine isolates of type II and III by bovine neutrophils. Nevertheless, greater than or equal to 35% of bacteria remained viable at the end of the phagocytosis incubation in 10% NBS. In contrast to human isolates, type II and III bovine isolates does not seem to require complement opsonization. These findings suggest that human isolates have higher opsonic requirements (148).
Phase variation in CPS expression has been clearly demonstrated for human isolates and was also reported for bovine isolates of type IV. Phase variation was suggested as playing an important role during colonization and adhesion to epithelial cells (nonencapsulated variants), and in phagocytosis resistance (encapsulated variants) (149).
Hemolysin
The beta-hemolysin of S. agalactiae is expressed by the vast majority of human strains and it appears to be a surface-associated molecule (150) . Due to a rapid loss of hemolytic function in bacterial extracts, the biochemical nature of the molecule has not been elucidated yet. Attempts to identify and characterize the hemolysin by generating antibodies have not been successful. A strong correlation exists between the amount of hemolytic activity and the production of an orange-red pigment, suggesting a very close genetic linkage between these two properties (151, 152) . Indeed, it was recently reported that the cyl operon of GBS are involved in both the production of hemolysin and pigment (153) . In contrast to human strains, bovine isolates are usually non-pigment producing and non-hemolytic, while isolates from other animals were shown to behave similarly to those from humans (143) . Nevertheless, beta-hemolysin production in bovine GBS has been reported for some isolates (141, 154) . In human infections, production of beta-hemolysin by GBS has been correlated with lung epithelial cell injury in vitro, suggesting a possible pathogenic role of this enzyme in the invasive step of early-onset GBS disease (136) . The role of GBS hemolysin in animal infections, if produced, is so far unknown.
Pyrogenic exotoxins
Production of a novel pyrogenic toxin was reported in GBS strains from patients with streptococcal toxic shock-like syndrome (TSLS). The purified toxin presents a molecular weight of 12 kDa and was pyrogenic in rabbits, enhanced the susceptibility of the animals to lethal endotoxin shock, and caused the proliferation of rabbit splenocytes; these properties define pyrogenic toxins. When given to rabbits via a subcutaneous miniosmotic pump, the toxin caused TSS-like symptoms ending in death (155) . The presence of a polysaccharide exotoxin, named CM101, was also reported from infants with sepsis, as well as from GBS culture media. CM101 induces a complement-activated cytokine-driven inflammatory response (156) . No such a toxin was reported to date in animal isolates of GBS.
Hyaluronidase
It should be noted here that the extracellular GBS enzyme described in numerous reports as a neuraminidase is in fact a hyaluronidase, also named in the literature as hyaluronate lyase (157) . The enzyme was purified and characterized as a 116 kDa secreted protein encoded by the gene hylB (158, 159) . Production of hyaluronidase is found at high frequency in bovine isolates (141, 160) . S. agalactiae isolates from diseased pigs and an equine isolate of serotype Ia/cbeta were also shown to be hyaluronidase positive (64, 161). In contrast, isolates of GBS type III of canine and feline origin, and isolates of serotype III/Rib of equine origin were shown to be hyaluronidase negative. Canine, feline and equine origin GBS seem to be more related to human isolates, which were also reported as hyluronidase negative in the same study, indicating some epidemiological relationship (141, 161) . This is in contrast to a previous study reporting production of hyaluronidase in 75% of human clinical isolates of GBS (160).
Little is known about the exact role of GBS hyaluronidase in the pathogenesis of the infections caused by GBS. Hyaluronidase was suggested as an important virulence factor that helps this pathogen to break through the biophysical barrier of the host tissues by the enzymatic degradation of hyaluronan and certain chondroitin sulfates at beta-1,4 glycosidic linkages. Characterization of the purified enzyme revealed that it degrades hyaluronan by a mechanism different from that of other previously studied hyaluronidases. Instead of randomly cleaving hyaluronan chains leading to a continuous decrease in average chain size, the GBS enzyme initially yields primarily unsaturated disaccharides. Such a function of the enzyme would destroy the normal connective tissue structure of the host and expose the tissue cells to various bacterial toxins (162) (163) (164) . Strains producing high levels of hyaluronidase were frequently found to be more virulent. Although it was not possible to experimentally demonstrate a relationship between the increased virulence in mice and the enzyme production (165), it could be involved in bacterial dissemination as already discussed for the above mentioned mastitis-associated pathogens. In addition, it has been suggested that there is a strong possibility that the enzyme may also subvert some normal host defense mechanisms since hyaluronan and molecules that bind to it are involved in numerous immune system functions (159).
CAMP-factor
The CAMP factor (co-hemolysin) of GBS is a secreted 25.3-kDa protein encoded by the gene cfb (166) , and is one of the most studied co-hemolysin. GBS from human and animal origins were reported to be CAMPpositive (143, 161) . However, phenotypically CAMPnegative S. agalactiae isolates from cows with mastitis have also been reported; although some isolates did not carry the cfb gene, others were shown to harbour a normal sized CAMP-factor encoding cfb gene, indicating a reduced expression of CAMP-factor or a gene defect elsewhere along the pathway of expression (130, 166, 167). A close relationship was reported between the CAMP gene of S. agalactiae and those of S. pyogenes, S. canis, and S. uberis (130).
Besides its role in co-hemolysis, the CAMP protein binds in a nonimmune reaction with the Fc part of immunoglobulins G and M, leaving the Fab sites active (168) . Although the role of CAMP factor in pathogenesis is unclear, several investigations suggest that the release of this protein during systemic infections could impair the host immune response. In addition, partially purified CAMP factor was found to be lethal for rabbits (132), and purified CAMP factor, although not lethal in mice, did increase the virulence of various GBS isolates (169) . Recently, it was shown that S. agalactiae CAMP factor forms discrete transmembrane pores on susceptible membranes by an oligomeric mode of action; however the role of CAMP factor as a pore-forming toxin remains unclear (170).
Superoxide dismutase
S. agalactiae has been shown to possess a gene that encodes a manganese-dependent SOD (2, 171). S. agalactiae is a facultative anaerobe, which, like all streptococci, lacks catalase. The absence of this enzyme in this bacterial genus suggests that SOD could play an important role against oxidative stress, affecting both the survival and, consequently, the virulence of the bacteria. The presence of SOD could be of pathogenic advantage for the bacterium, since it was shown that in the absence of opsonins, GBS is able to enter and survive inside phagocytes (172) . The construction of a sodA-disrupted mutant by allelic exchange allowed for an examination of the role of this enzyme in the pathogenicity of GBS. In mouse bone marrow-derived macrophages, the sodA mutant showed an increased susceptibility to bacterial killing by macrophages. In a mouse infection model, the survival of the sodA mutant in the blood and the brain was markedly reduced in comparison to that of the parental strain. These results suggest that SodA plays a role in the pathogenesis of GBS infection by enabling bacteria to survive in the phagosome of macrophages or to the oxidative burst triggered by phagocytosis (173) . In addition, the involvement of toxic oxygen intermediates in the bacteriostatic effect of milk has been reported, and thus the presence of SOD could be of adaptative advantage for GBS during infection of the mammary gland. However, this hypothesis remains to be confirmed.
Bacteriocins
Bacteriocin-like activity was reported in few GBS isolates of animal and human origins (80) . No further information is available on the nature or the role of these inhibitory products in GBS colonization or survival as part of the normal flora in animals or humans.
STREPTOCOCCI OF EQUINE ORIGIN

Streptococcus equi subsp. equi
Streptococcus equi (Lancefield group C) comprises the two subspecies, S. equi subsp. equi and S. equi subsp. zooepidemicus. Subspecies equi is the causative agent of strangles, a worldwide-distributed and serious disease of the equine upper respiratory tract. Subspecies zooepidemicus is considered an opportunistic commensal, often present in the upper respiratory tract of healthy horses; however, after stress or a virus infection, it can cause a secondary infection, which results in strangles-like symptoms. Subspecies equi is virtually confined to horses, whereas subspecies zooepidemicus also infects a wide range of other animals, such as pigs, dogs, cats, sheep and cows. Human cases with infection due to subspecies zooepidemicus have also been reported (174, 175) . Isolates of subspecies equi are serologically and genetically very homogeneous, whereas isolates of subspecies zooepidemicus display a high degree of heterogeneity. Subspecies equi is thought to be a clone derived from subspecies zooepidemicus (176, 177).
As mentioned above, S. equi subsp. equi (which will be referred through out the text as S. equi) is the aetiological agent of strangles, a highly contagious purulent disease of the upper respiratory tract of the family Equidae (178) . The disease is initially characterized by nasal discharge and fever, followed by abscess formation in local lymph nodes. In fact, S. equi spreads rapidly to the lymph nodes of the head where bacterial multiplication proceeds unhindered by a massive infiltration by polymorphonuclear leukocytes. Early lymphadenitis progresses to abscessation and finally pus drain through the nearest site of egress, either through the skin or upper respiratory tract mucosa. This process, involving one or more lymph nodes, can last for 2-3 weeks and is usually associated with depression, loss of apetite, pyrexia, mucopurulent nasal discharge and inspiratory dyspnoea. Abscesses can form in other body organs and their rupture is fatal in up to 10% of cases (bastard strangles; (179)). Morbidity rates of up to 100% have been reported, and current antibiotic therapy is often ineffective and thus recent attention has focused on vaccine development (180). Harrington et al. (180) suggested that a systematic understanding of S. equi virulence, leading to the identification of targets to which protective immunity can be directed, is a prerequisite for the development of a successfully vaccine. In a recent publication (180), the authors extensively reviewed the knowledge on S equi virulence factors which will be summarized and updated below.
Hyaluronic acid capsule
S. equi is described as being highly encapsulated giving it a "honey dew" appearence. The S. equi hyaluronic acid capsule is constitutively expressed and is an important virulence factor which protects bacteria from phagocytic killing (180) . Indeed, in vivo pathogenicity and resistance to intracellular killing of S. equi strains correlate with levels of capsule expression (181, 182) . As mentioned aboved, capsule synthesis in the pyogenic streptococci is directed by genes of the hyaluronic acid synthesis ( has) operon and has been extensively studied in S. pyogenes (111). Analysis of the has operon in S. equi indicated that hasA, hasB and hasC have sizes and organisation similar to those of S. pyogenes . An interesting, and as yet unexplained finding was that of an additional copy of hasC in another region of the S. equi genome. Since hasC is not essential for capsule production in S. pyogenes, it is possible that the additional copies in S. equi are indicative of another role for the hasC gene product (183) .
The hyaluronic acid capsule is non-antigenic and so is not involved in protective immunity (184) . However, a hyaluronate associated protein (HAP) is present in the capsule and confers partial protection in murine models of S. equi infection (185) . Recently, a specific mutation of the hyaluronate synthase (hasA) gene in Pinnacle (an avirulent strain widely used for vaccination in North America), permanently abolished the production of capsule and provided an easily recognisable genetic marker. This deletion mutant should serve as a useful candidate to replace Pinnacle since it cannot revert to a mucoid phenotype and can be genetically distinguished from wild type strains (183) . The use of this mutant in phagocytosis and killing assays would further confirm the importance of the capsule in bacterial virulence, as suggested by previous studies using non-encapsulated variants or hyaluronidase-treated strains. Unfortunately, these assays have not yet been performed.
M-like proteins
It has been early shown that the adherence of S. equi to cheek and tongue cells isolated from adult ponies was trypsin-sensitive and could be inhibited by preincubation of cells with a purified M-like protein of S. equi or by an antiserum raised to this M-like protein (186) . It was later reported that S. equi possesses genes encoding two M-like proteins, one of which (FgBP or SeM) is unique to S. equi while the other (SzPSe) is a homologue of the Mlike protein SzP produced by subspecies zooepidemicus. Both FgBP and SzPSe show strong binding to equine Fg (180, 187) . Of these, FgBP is by far the most dominant wall-associated protein expressed by virulent S. equi (187, 188) . FgBP is structurally and functionally similar to the well-studied M protein of S. pyogenes, with the ability to bind equine Fg, as well as the Fc fragment of equine IgG. Binding activity to human, rabbit, pig and cat IgG has also been reported (189) . The efficiency with which FgBP binds Fg from different animal species decreases in the order with horse, mouse, pig, rat, sheep, dog, bovine, and human Fg (190) . The protein reacts with convalescent horse serum and protects mice against lethal infection with virulent S. equi (188, 191, 192) . The sequence of the corresponding gene (fbp) has been determined and shown to encode a protein of 534 amino acids (58.3 kDa), which possesses some structural and sequence similarities to other streptococcal cell wall proteins. However, the protein shows little significant sequence similarity to other M-like proteins, except for the Fg/IgG-binding DemA protein from S. dysgalactiae, where some similarities in the A-repeat and C-terminal regions have been noted (95) . The acquisition of FgBP, in S. equi but not in subspecies zooepidemicus, has been postulated to be one of those key elements which suggests that S. equi is a clone derived from subspecies zooepidemicus. Furthermore, the absence of variation in the immunogenic M-like proteins FgBP and SzPSe of S. equi is striking and contrasts with the situation in S. pyogenes and S. zooepidemicus in which the M and M-like SzP proteins, respectively, are highly variable (177, 187) .
Early studies showed that S. equi cells are resistant to non-immune phagocytosis, and there is some indirect evidence indicating that M-like proteins may be involved in this process (180, 182, 191, 192) . Recently, an fbp knockout mutant which does not express FgBP on the cell surface has been constructed. The mutant does not bound equine Fg or IgG-Fc, it is rapidly killed in whole horse blood, and showed greatly decreased virulence in a mouse model. The use of this mutant convincingly demonstrated that FgBP plays a role in resistance to phagocytic killing and in virulence (189) . Additional supporting evidence that FgBP is important in S. equi infection of the target species comes from a recent study of horses that were outwardly healthy but were shown to be persistent carriers of S. equi. Streptococcal isolates from about 25% of these carrier animals expressed truncated forms of FgBP (lacking the N-terminal Fg-binding region) and were more sensitive to phagocytosis (193) . Full resistance to phagocytosis, however, is likely to be the sum of the activities of a number of S. equi products, including the capsule. Consequently, the reduced resistance to phagocytosis of the variant S. equi strains may only be partial and insufficient to compromise the ability to persist in the guttural pouches. The precise mechanism by which FgBP contributes to phagocytosis resistance remains to be elucidated. There is evidence that reduction in C3b deposition and Fg binding contribute to the ability of S. equi to resist killing by equine neutrophils (191, 192) . These aspects of the antiphagocytic activity of M-like proteins have been previously reviewed (180) . The ability of FgBP to bind IgG-Fc suggests another possible mechanism for resistance to phagocytosis (189) . On the other hand, the contribution of the second M-like protein, SzPSe, to the virulence of S. equi is little known and seems to be less important to that of FgBP (187).
Secreted fibronectin-binding protein
S. equi has the potential to express several wallassociated proteins with host-protein binding properties, such as the FN-binding protein (FNE or SFS; (194, 195) ), and the alpha 2 -macroglobulin/albumin/IgG-binding protein (ZAG), which is also present in the subspecies zooepidemicus (176) . Interestingly, the FNE protein was found to be secreted into the culture medium (195) . Sequence comparison of the fne and fnz genes (coding for a FN-binding protein in subspecies zooepidemicus) revealed only minor differences (195) . The reading frame of fne is interrupted due to a one-base deletion present in the middle of the gene and, as a consequence, only the 5'-terminal half of fne is translated in S. equi. Thus, FNE protein was found to have a signal peptide, but is lacking the COOHterminally located sequence motifs involved in cell wall anchoring, which is logical for a secreted protein (195) . Whether it is cell surface-attached protein that has been released during the cultivation or is actively secreted into the growth medium is not clear, but it could be a mechanism similar to that reported in S. pyogenes for the release of large biologically active fragments of cell surface proteins (6) . It has been shown that FNE inhibits the binding between FN and collagen which could have as consequence the disturbance of physiologic processes like wound healing, where the interaction between collagen and FN constitutes an important step (194) .
As already mentioned it has been proposed that S. equi is a clone derived from subspecies zooepidemicus and that certain evolutionary changes turned it from a commensal to a pathogen. The finding that S. equi isolates secrete an Fn-binding protein whereas the tested subspecies zooepidemicus isolates do not, also reflects a distinct difference between the two subspecies. Thus, there is a possibility that the deletion of one base in fnz has also contributed to change a commensal to a pathogen (195) .
Hemolysin
On blood agar S. equi shows a zone of betahemolysis. This hemolytic activity has been characterized as being dependent on an equine serum supplement and the logarithmic phase of growth, after which activity declined sharply (196) . Hemolysis was not affected by cholesterol, was only slightly increased in reducing conditions and was completely inactivated by trypan blue, identifying the hemolytic activity as streptolysin S-like (SLS-like). On the other hand, a lambda phage library of S. equi was shown to contain plaques whose hemolytic activity was enhanced by reducing conditions and inhibited by cholesterol, suggesting a streptolysin O-like (SLO-like) activity. However, it was later demonstrated by the authors that isolates of S. equi in medium without SLS-like inducers show no SLO-like activity and no evidence for an SLO-like toxin could be found by immunoblotting with pneumolysin antiserum and monoclonal antibodies, or by polymerase chain reaction with primers derived from sequences conserved between the SLO genes of Lancefield group A, C and G streptococci. Thus, S. equi does not appear to possess a SLO but does make a SLS-like toxin whose production can be interrupted at just one genetic locus (196) . The precise role of this toxin in the virulence of S. equi is so far unknown.
Pyrogenic exotoxins
The recent discovery of potent mitogenic and pyrogenic activity in culture supernatants of S. equi isolates (197) lead to the characterization of two pyrogenic mitogens, SePE-H and SePE-I, which have molecular masses of 27.5 and 29.5 kDa, respectively, and each is almost identical to its counterpart in S. pyogenes (198) . The pyrogenic exotoxins of the later species, including SpeA, C, and F, are members of a family of proteins with high immunomodulating capacity and hence have been termed superantigens. Superantigens are crucial molecules in toxic shock syndrome (199) . In this regard, many of the clinical features of acute strangles, including fever, neutrophilia and fibrinogenemia, are characteristic of an acute phase response associated with proinflammatory cytokine release induced by pyrogenic exotoxins. The genes coding for the two S. equi exotoxins were shown to be adjacent to a gene encoding a phage muramidase of 49.7 kDa and are located immediately downstream from a phage genomic sequence almost identical to a similar phage sequence in S. pyogenes. Strong mitogenic responses were elicited by both proteins from horse peripheral blood mononuclear cells. However, although both were pyrogenic for rabbits, only SePE-I was pyrogenic in ponies. Convalescent sera contained antibody to each mitogen and horses recovered from strangles or immunized with SePE-I were resistant to the pyrogenic effect of SePE-I. The immunogenicity of SePE-I suggests that it should be included in new generation strangles vaccines. Sepe-I and sepe-H were consistently present in isolates of S. equi, but they were absent from the closely related subspecies zooepidemicus, suggesting that phage mediated transfer was an important event in the formation of the clonal, more virulent, S. equi from its putative S. zooepidemicus ancestor (197, 198) . In addition, the presence of mitogenic exotoxins in S. equi would explain the difference in clinical severity of strangles compared to the generally milder, less systemic disease caused by subspecies zooepidemicus infection of the upper respiratory tract (180) . Recently, two novel streptococcal superantigen genes (speL Se and speM Se ) were identified from the S. equi genome database. However, the novel superantigen genes could not be found in any of the analyzed S. equi isolates, suggesting that they are rare in this species (200).
Streptokinase
As mentioned above, the group C streptococci S. equi, isolated from non-human hosts, have been regarded during years as non-streptokinase producers simply on the basis of the inability to activate human plasminogen. However, it was demonstrated that S. equi isolates from equine origin secreted a streptokinase which specifically activates plasminogen obtained from equine plasma but not from human or porcine plasma. It was suggested that species-specific plasminogen activation may be an early step in events resulting in infection and may determine the selective virulence of this bacterium for certain host (85) . As shown for S. pyogenes, as well as other group C streptococci, S. equi not only produces a plasminogen activator but also binds the generated plasmin, thus providing the bacteria with unregulated proteolytic activity (85) . This process may be an important contributor to the tissue-invasive properties of this pathogen.
Hyaluronidase
Some isolates were shown to produce extracellular hyaluronidase activity which was associated with a protein of approximately 55 kDa (99) . It was suggested that hyaluronidase activity may be required for penetration of mucous membranes and tissue spread but it is also likely to be important in the utilisation of host hyaluronic acid, an abundant carbon source and possibly in the recycling of released capsular hyaluronic acid (180) . Conversely, hyaluronidase can remove hyaluronic acid capsule, and perhaps render encapsulated organisms more sensitive to phagocytosis (201) . The hyaluronidase expression was related to a lysogenic bacteriophage in some isolates of S. qui (201).
Proteases
Clinical isolates of S. equi have been shown to produce extracellular enzymes capable of degrading number of protein substrates including Fg, gelatin, and casein. In fact, S. equi was shown to produce at least two easily detectable proteases, and the caseinolityc activity was associated with a 29 kDa putative cysteine protease that could be detected in both cell-associated and supernatant fractions. It was suggested that this activity could be involved in the cleavage of M-proteins (202).
Superoxide dismutase
S. equi has been shown to posses a gene that encodes a manganese-dependent SOD although its role in combating oxidative stress has not been investigated (2).
Streptococcus equi subsp. zooepidemicus
The very closely related organism S. equi subsp. zooepidemicus (referred here as S. zooepidemicus) is associated with several syndromes including endometritis in susceptible mares and it is one of the most frequent causes of infectious abortion and placentitis, pneumonia and shipping fever. It is also associated with lower airway inflammation in foals and Thoroughbred horses in training, and there is growing evidence of close involvement with repeated respiratory tract infections from life as a foal to horses of 3 to 4 years of age. It was also related to outbreaks of bovine mastitis (203) . As it is the case of S. equi, despite the considerable animal suffering and economic burden associated with these diseases, there is little information regarding the molecular basis of virulence, and there are presently no effective vaccines against this organism (178).
Hyaluronic acid capsule
As described for S. equi, the capsule of S. zooepidemicus was suggested to be antiphagocytic as it inhibits the ingestion of bacteria by pulmonary phagocytes and leads to increased severity of infection. It was reported that isolates with high concentrations of cell-associated hyaluronic acid were more resistant to phagocytic killing (204) . In vivo up-regulation of capsule expression has been suggested as an important factor in opportunistic invasion by S. zooepidemicus. In fact, colonies of S. zooepidemicus isolated from tonsillar specimens were uniformely nonmucoid, while the organism is encapsulated in smears of lungs and mucopurulent material from foals with pneumonia or bronchitis. In addition, S. zooepidemicus quickly becomes encapsulated and more virulent in the lungs of mice experimentally infected via aerosol exposure. It was concluded that capsule expression is important for survival and proliferation in tissues (204, 205) .
It was reported that the hyaluronic acid capsular material not only helps bacteria to resist phagocytosis by macrophages, but also contributes to adherence properties of S. zooepidemicus (206) . Indeed, whilst the direct role of the hyaluronic acid capsule in adherence of S. equi has received little attention, it is interesting to note that the hyaluronic acid capsule plays a significant role in the adherence of S. zooepidemicus to HeLa cells (180) .
The hyluronic acid nature of the S. zooepidemicus capsule makes it non-immunogenic, and, as shown for S. equi, the hyaluronate-associated protein (HAP) is in fact responsible of confering partial protection in a murine model of S. zooepidemicus infection (185) . To the best of our knowledge, isogenic non-encapsulated mutants of S. zooepidemicus have not been reported so far. The construction of this type of mutant will help to elucidate the role of the capsule in the pathogenesis of this bacterial infection.
M-like proteins
As mentioned above, S. zooepidemicus possesses a M-like protein, named SzP, responsible for great antigenic variation. Variations are found at its amino Nterminus, in a central hypervariable region, as well as in a proline-rich region close to the membrane anchor (207) . This variation, together with sequence differences, is potentially useful in recognition of strains of S. zooepidemicus in clinical specimens and tissues of healthy horses. However, it was shown that SzP phenotype is not an important determinant of invasiveness or epizootic capabilities (204) . On the other hand, opsonic and mouseprotective responses to SzP are, at least in part, not serovar (SzP phenotype) specific (207) .
The M-like protein gene was cloned and it encodes for a protein with a molecular weight of 40 kDa which protects mice against S. zooepidemicus infection and stimulates the production of antibodies which opsonize S. zooepidemicus but not S. equi. The predicted amino acid structure shows significant homology with only the carboxy terminus of M proteins of streptococci of Group A and G. The M-like protein, although showing an extensive region of alpha helix, lacks the A, B, and C repeats found in M proteins of S. pyogenes and has a shorter signal sequence (208) . The role in virulence of protein SzP has not yet been determined; however, this protein was shown to bind Fg, and thus may contribute to bacterial survival in tissues by blocking phagocytosis and/or phagocytic killing (187).
Other putative virulence factors
Streptokinase and hyaluronidase production have been reported in S. zooepidemicus isolates (85, 99, 209) , as well as a gene that encodes a manganese-dependent SOD (2). Their role in virulence is poorly characterized. No hemolysin or cytotoxin has been fully characterized to date for this subspecies, except for a report of increased antistreptolysin O titers in S. zooepidemicus infected horses (210) , and a report of hemolytic activity produced by an animal isolate which was shown to be resistant to cholesterol treatment (81) . Thus, these two reports are contradictory with regard to the possible nature of the S. zooepidemicus hemolysin.
Bacteriocins
S. zooepidemicus was shown to produce a lytic enzyme, zoocin A, which specifically target the cell walls of some closely related streptococcal species. The gene encoding zoocin A (zooA) was cloned and the sequence of zooA determined (211) . The N-terminal region of zoocin A had a high degree of homology to the N-terminal region of lysostaphin, an endopeptidase produced by Staphylococcus simulans biovar staphylolyticus that specifically targets the cell walls of some staphylococcal species and to a number of other enzymes with peptidase activity (212) . Flanking zooA in a back-to-back orientation was reported a gene named as zoocin A immunity factor (zif), responsible for protecting the producer strain from the otherwise lethal action of its own product (213) . The functional role of enzymes such as lysostaphin and zoocin A has been widely debated. They are clearly related to cellular peptidoglycan hydrolases which are essential for various cellular functions, including cell wall expansion, cell wall turnover, and cell separation, but unlike these enzymes they do not remain cell associated. Their release into the extracellular medium, combined with their high target specificity, supports the concept that these enzymes are produced for the specific purpose of killing closely related bacterial species (214).
Streptococcus pneumoniae
Many of the capsular types of S. pneumoniae in man are important worldwide cause of pneumonia, meningitis and septicemia, as well as the non-invasive diseases otitis media, sinusitis and bronchitis in humans. Virulence factors and the pathogenesis of human disease caused by this microorganism have been previously reviewed (215, 216) . S. pneumoniae was first isolated from horses during a study of the virological causes of respiratory diseases in Switzerland. Reports of sporadic isolation from various types and age of horses followed. Since then, the importance of this bacterium as a cause of inflammatory airway diseases (IAD), a moderate to gross excess of mucopus in the trachea, complicated with cough and pyrexia, increased considerably. All equine isolates recovered to date have been reported as capsular type 3 (217, 218) . Knowledge of virulence factors and pathogenesis of pneumococcal infection in horses is limited. Recently, molecular characterization of a group of S. pneumoniae isolates obtained from horses from geographically distinct locations showed that they represent a tight clonal group, virtually identical to each other but genetically distinguishable from more than 120 divergent isolates of human S. pneumoniae. A comprehensive analysis of known pneumococcal virulence determinants was undertaken in an attempt to understand the pathogenicity of equine pneumococci. Surprisingly, equine isolates appear to lack activities associated with both the hemolytic cytotoxin pneumolysin, often considered a major virulence factor of pneumococci, and the major autolysin gene lytA, also considered an important virulence factor. In support of phenotypic data, molecular studies demonstrated a deletion of parts of the coding sequences of both lytA and ply genes in equine pneumococci (219) . Phylogenetic analysis clearly shows that equine pneumococci cluster within the normal human-infecting population and do not form a separate, deeply branching group. The apparent uniformity among isolates could suggest that the movement of pneumococci from humans to horses was a relatively recent event and that the isolates examined are part of a recent epidemic clone that has spread throughout Thoroughbreds (219) . The implications of the alterations in genes believed to encode two of the major virulence factors of S. pneumoniae for that organism's pathogenicity in horses remain unclear. Although functional pneumolysin and autolysin are important in several murine models of infection and a functional pneumolysin is responsible for damage to the ciliated cells in the respiratory tract, there is evidence that the inactivation of pneumolysin in some human S. pneumoniae isolates has little impact upon their virulence in some models of infection. Although the extent of lung pathology seen in horses is generally less than that seen in lobar pneumonia in humans, the overall severity of pneumococcal disease seen in the two hosts may be similar.
STREPTOCOCCI FROM OTHER ANIMAL SPECIES
Streptococcus iniae
A large variety of Gram-positive cocci in chains has been isolated from aquatic animals, including frogs, crabs, prawn and shrimp, fish and mammals. In cultured fishes, streptococcal infections often develop into a lethal septicemia. Fish from both freshwater and marine environments may be affected, and farms in many parts of the world have consequently suffered serious economic losses. The taxonomic position of many aquatic isolates is still controversial but, as a whole, Streptococcus spp. has been recently listed among the emerging problems in aquaculture (220) (221) (222) .
S. iniae, first isolated in 1976 from a subcutaneous abscess of a captive freshwater dolphin (223) , causes meningoencephalitis and death in cultured fish species. S. iniae may colonize the surface of fish or cause invasive disease associated with 30 to 50% mortality in affected fish ponds. Infected tilapia become lethargic, swim erratically, have dorsal rigidity, and die within several days. Pathological studies show extensive infection in the central nervous system, with subarachnoid hemorrhages and parenchymal mononuclear infiltrates. These symptoms are not seen in the peracute form of the disease which is characterized by a sudden death and the diagnosis is possible only by recovering streptococci from infected organs, mainly the brain (138, 224) . S. iniae has more recently been reported to cause fulminant soft tissue infection in humans, with associated bacteremia (225) . However, results of a recent study do not support the contention that S iniae is a serious public health threat associated with commercially raised fish; rather, it represents a limited risk for older or immunocompromised people who incur puncture wounds while handling and preparing fish (226) .
S. iniae has been well characterized biochemically (223) . However, with regard to potential virulence factors, no clear phenotypic differences between disease-associated and commensal strains have been reported. Data on S. iniae infection in experimental animals are limited. Early studies reported that rabbits, guinea pigs, and mice were resistant to subcutaneous, intravenous, and intraperitoneal injection of 10 8 CFU of S. iniae type strain, ATCC 29178 (227) . Conversely, meningo-encephalitis in cultured fish was reproduced in both trout and tilapia following fish-fish passage of a diseased-fish isolate (138) . In this model, highly virulent strains did not differ from low virulent strains by any identifiable extrachromosomal elements (138) . Experimental infection was later reproduced with isolates from diseased fish in different fish species (228) (229) (230) .
Fuller et al. (231) recently reported a murine subcutaneous infection model for S. iniae local tissue necrosis and bacteremia. The ability to cause bacteremia in this model is associated with a genetic profile unique to strains responsible for disease in fish and humans (231) . This suggests that specific, chromosomally encoded virulence determinants may account for the pathogenicity of the clonal (disease-associated) versus non-diseaseassociated (commensal) strains. Although a commensal strain does not induce invasive disease in mice, even at high inoculum, it does give rise to a localized necrotic lesion at the site of inoculation, as does a disease-associated strain (232) . One of the few distinguishing phenotypes of S. iniae is the zone of beta-hemolysis surrounding colonies cultured on blood agar media. The S. iniae cytolysin that confers the hemolytic phenotype has recently been characterized (232) . The cytolytic activity, examined by using a hemolysis assay, was found to be associated with whole-cell preparations but absent in culture supernatants. A chromosomal region with significant homology to the SLS biosynthetic operon sag in S. pyogenes was identified as being the genomic region responsible for cytolysin expression. The sag-like gene cluster in S. iniae was further characterized and comprises 9 genes named as sagA to sagI. Confirmation that the S. iniae cytolysin is a functional homologue of SLS was achieved by PCR ligation mutagenesis, complementation of an SLS-negative S. pyogenes mutant, and use of the SLS inhibitor trypan blue. Transposon (Tn917) mutagenesis studies revealed that S. iniae SLS expression is required for local tissue necrosis but does not contribute to the establishment of bacteremia in the mouse model (232) . Since the SLS is present in both, the commensal and the disease-associated strains tested so far (232), it could not explain by itself the differences in the capacity to induce invasive disease between these two groups of strains.
It was further reported that disease-associated strains are cytotoxic to human brain microvascular endothelial cell (BMEC) as measured by lactate dehydrogenase release from host cells. However, both disease-associated and commensal strains adhere to and invade cultured human epithelial HEp-2 cells and BMEC cells equally well. While cellular invasion may still contribute to the pathogenesis of invasive S. iniae disease, direct cytotoxicity appear to be a discriminating virulence attribute of the disease-associated clone (231) . The authors suggested that damage to endothelial layers could aid bacterial access to the bloodstream and systemic spread, as observed in the murine model. Furthermore, the meningoencephalitis reported in fish disease may be attributed in part to the ability of S. iniae to promote injury and disruption of endothelial cells of the blood-brain barrier (231) . It is not yet clear if SLS is related to cytotoxicity to BMEC cells or a second unknown toxin is in fact responsible of this discriminating phenotype.
One of the features that may allow S. iniae to stablish an invasive infection is related to the ability to induce high bacteremia and to overcome the immune response of phagocytic cells. In this regard, diseaseassociated strains have been found to be more resistant to phagocytic clearance in a human whole blood killing assay compared to commensal strains, which were almost entirely eradicated (231) . However, this difference was not observed with trout whole blood (233) . By using salmonidspecific cellular models, Zlotkin et al. (233) recently demonstrated that disease-associated strains are able to invade and persist within phagocytic cells and to induce their apoptosis. It was suggested that survival within phagocytes coupled to their apoptosis may play a crucial role in S. iniae infection. In addition, it may provide the pathogen an efficient mechanism of translocation into the central nervous system (233) . The virulence factors, such as the capsule, involved in these processes remain to be characterized. Although S. iniae was originally described as an encapsulated organism (223) , and mucoid colonies, characteristic of encapsulation, were reported in a fish infection model (138) , the presence of a CPS has only recently been reported for the first time (234) . In addition, a shift in "capsular composition" was suggested to be responsible of the emergence of a vaccine-resistant new serotype (235) . However, the role of the CPS in the pathogenesis of S. iniae infection or in the above described interactions with phagocytes still remains unknown. In this regard, although M-like surface proteins, which render certain groups of streptococci resistant to phagocytosis, have not been identified in S. iniae, the existence of an uncharacterized surface component or even a secreted factor that might interfere with phagocytosis, as described for SpeB of S. pyogenes (236) , cannot be excluded. The production of SLS by S. iniae does not seem to be involved in resistance to clearance in the human whole blood assay (232) ; and, although the presence of a gene encoding for a manganese-dependent SOD has been reported, the role of this enzyme in resistance to phagocytic killing is so far unknown (2).
Finally, it has been shown that some isolates of S. iniae increase necrosis of nonspecific cytotoxic cells (NCC), with consequent associated enhancement of inflammatory responses in tilapia fish. This would be a definite selection disadvantage for S. iniae. In contrast, other isolates negatively immunoregulated NCC activity, and in these cases infection and disease would likely occur (237, 238) . To date the putative virulence factors implicated in immunoregulation of NCC cells are largely unknown.
Streptococcus canis
S. canis is a species originally proposed in 1986 (239) for streptococci isolated from dogs and cows possessing the Lancefield Group G antigen. It has since been isolated from a variety of other animals including cats, rats, mink, mice, rabbits, and foxes, and it causes opportunistic infections in these species. Human infections with S. canis are extremely rare (240, 241) , although probably underestimated because the routine identification of beta-hemolytic streptococci is based only on Lancefield's serological grouping, which is often falsely considered to be species specific. The occurrence of such infections probably requires close contact between a domestic animal and a skin wound such as a burn or ulcers (242) .
Although S. canis isolates may often represent commensal flora of the canine skin and mucosa, they have been involved in a variety of canine diseases associated with urinary tract infections, abortion, vaginitis, metritis, mastitis, polyarthritis, and skin infections. In addition, severe invasive S. canis infections in dogs, analogous to human streptococcal toxic shock syndrome (STSS) and necrotizing fasciitis (NF), have been reported, highlighting our lack of knowledge regarding the mechanisms of virulence of this microorganism (243, 244) . Indeed, assessment of reports of virulence factors in S. canis is difficult since many authors refer to streptococcal isolates only as Lancefield serological group G, without clealry distinguishing by species, source or biotype between animal or human sources (243) . An initial description of the first seven S. canis isolates from canine STSS and/or NF reported that they lacked genes homologous to S. pyogenes virulence determinants including the streptococcal pyrogenic exotoxins SpeA and SpeF, the streptococcal cysteine protease SpeB, the C5a peptidase, and two enzymes responsible for hyaluronic acid capsule synthesis, HasA and HasB (244) . Other reports have also indicated the absence of C5a peptidase activity and its encoding gene scpA, in group G strains isolated from dogs and cows (245) , as well as the absence of streptococcal mitogenic factor (mf) gene in S. canis isolates (246) . On the other hand, reports on the presence of M or M-like proteins in S. canis are contradictory. In fact, genes encoding M proteins, which are a major virulence factors in the human pathogen S. pyogenes, were reported in earlier studies to be present in human but not in animal group G streptococci (247, 248) . However, in a more extensive study of a larger number of isolates of S. canis from cases of canine STSS and/or NF, the presence of genes encoding homologous to M protein as well as proteinaceous cell surface fibrillae consistent with M protein has been reported (243) . The authors also confirmed lack of other recognized virulence genes with significant homology to those in S. pyogenes (including the superantigens SpeC and Ssa, and streptokinase A). However, these results do not rule out the possible presence of similar proteins with low nucleotide homology (243) .
Thus, M-like proteins remain as putative virulence factors for S. canis. On the basis of the concept that the expression of M protein is the factor mainly responsible for conferring streptococci the ability to resist phagocytosis (92, 249) , a correlation was established with the presence of M proteins and the ability of S. canis to resist phagocytic killing in a canine whole blood model, as deducted by increased bacterial multiplication (243) . In addition, the expression of M proteins may also explain the ability of S. canis to bind several plasma proteins (250, 251) .
It was also shown that S. canis hybridized with the SLO gene probe, suggesting that S. canis may encode for SLO (243) . SLO is broad spectrum cytolysin responsible for the beta-hemolysis observed on blood agar in the absence of oxygen, is cytolytic to a range of nucleated cells and induces an inflammatory response (47) . Thus, it is likely that this toxin is also a virulence factor in S. canis (243) . Still, it is not known if it is functionally expressed in this bacterial species.
Another investigated phenotypic characteristic of S. canis is the CAMP-like reaction reported by independent studies (252, 253) . While most canine isolates tested so far produce the CAMP factor, contradictory reports exist regarding this phenotypic characteristic in bovine isolates (239, 253, 254) . It is of interest to note that false-positive CAMP-like reactions have been reported due to SLO in S. pyogenes (255) . Nevertheless, the co-hemolysin or CAMP factor from the culture supernatant of a canine pathogenic S. canis strain has been purified and identified as a 18.6 kDa protein. The protein reacts with a homologous antiserum, appears to be trypsin-sensitive and relatively heat-stable (256) . A close relationship was reported among the CAMP-factor gene (cfg) of S. canis and those of S. pyogenes, S. uberis and S. agalactiae (130). As described above, for S. agalactiae, the CAMP factor was proposed to play a role in virulence by binding IgG and IgM in a nonimmune fashion which could lead to an impaired host immune response (168) . Although the S. canis CAMP-like factor did not show any non-specific IgG binding activities (256) , its role in virulence remains to be investigated. Almost all S. canis isolates tested to date produced proteases under different atmospheric conditions (252, 254) . The identity of the proteases and their role in virulence, if any, has yet to be determined. Nevertheless, they seem to be distinct from the S. pyogenes cysteine protease and the C5a peptidase, as mentioned above. Finally, and diferent from what it was observed for human group G streptococci, the absence of hyaluronidase and fibrinolysin activities in S. canis has also been reported (254) . The authors suggested that this may account for the increased virulence of human-origin isolates (254).
6.3.
Streptococcus bovis/equinus and
Streptococcus gallolyticus
The taxonomy of organisms designated Streptococcus bovis has a very complex history. S. bovis and Streptococcus equinus are listed as separate species in Bergey's Manual of Systematic Bacteriology (257) but were reported to be subjective synonyms (258) . The conclusions of the latter study were primarily based on DNA-DNA hybridization values. The specific epithet S. equinus has priority over S. bovis but is rarely used in human clinical bacteriology. In veterinary medicine, both names are in use. Recently, the situation has become more complex by the description of two novel species for strains originally identified as S. bovis: Streptococcus caprinus (259) and Streptococcus gallolyticus (260) . The epithet gallolyticus was derived from the ability of the strains to decarboxylate gallic acid. The presence of gallate decarboxylase, as well as tannase activities are characteristic of S. gallolyticus strains, confering them an adaptative advantage. The epithet caprinus referred to animals that forage on the same types of foods. However, later work revealed the synonymy of these two species, but the specific epithet gallolyticus has nomenclatural priority (261).
S. gallolyticus contains strains isolated from diverse habitats, including the feces of koalas, kangaroos, brushtail possums, ringtail possums, cows, horses, pigs, dogs, pigeons and guinea pigs, as well as animals with bovine mastitis, human clinical sources, and the sheep rumen, while most strains belonging to S. bovis are isolated from ruminants, such as cattle and horses (260) (261) (262) . Indeed, the predominant Streptococcus isolated from the rumen of animals is S. bovis. S. bovis is of particular interest because of its role in the development of lactic acidosis in cattle and sheep fed an excess of starch (263) . S. bovis strains are currently defined as a genomically heterogeneous group (3, 264).
The frequent association of S. gallolyticus with pathological conditions is noteworthy, not only among the animal strains but also among human lesion-derived strains. S. gallolyticus is also the most important etiological agent of septicemic streptococcosis in pigeons. The most important clinical signs of S. gallolyticus septicemia include sudden death, inability to fly, lameness, emaciation, polyuria and production of slimy, green droppings. Most typical lesions consist of extensive, well-circumscribed areas of necrosis in the pectoral muscle and arthritis of the knee, hock and shoulder joints (265) . However, the association of S. gallolyticus with pathogenicity is far from absolute, since these bacteria are also normal components of the intestinal flora of pigeons in many lofts, and certain serotypes are more virulent than others (262, 265) . In fact, within the S. gallolyticus species, different types have been recognized in pigeons: five biotypes, two sub-biotypes, five serotypes and six supernatant-phenotypes. Supernatantphenotypes are identified on the basis of the presence of either a T1 (70 kDa), T2 (68 kDa) or T3 (74 kDa) protein triplet and the presence (A+) or absence (A -) of the named protein A of 185 kDa in culture supernatants (266, 267) . There is a very strong correlation between the supernatantphenotype and the virulence of a given strain. Indeed, experimental infection studies have demonstrated that strains belonging to the A+T1, A+T2, A+T3 and A -T1 phenotype groups are highly virulent for pigeons. A -T3 strains appeared moderately virulent, whereas strains belonging to the A -T2 phenotype are low virulent for pigeons (266, 267) . Later, in a comparative study of cell wall protein profiles of several isolates of S. gallolyticus of differing virulence for pigeons, a band with molecular mass of 114 kDa was observed in isolates that belong to the highly virulent A+T1, A+T2, A+T3 and A -T1 culture supernatant phenotypes. A band with a slightly higher molecular mass (115 kDa) as well as a 207 kDa band were only detected in isolates that belong to the moderately A -T3 or low A -T2 virulent culture supernatant phenotypes. The 114-and 115-kDa bands were recognized by all homologous and heterologous pigeon sera used, whereas the 207 kDa band was only recognized by sera of pigeons infected with a A -T2 strain. Authors suggested that the 114, 115-and 207-kDa bands are useful as additional virulence associated markers for pigeon S. gallolyticus strains (268) . A similar association of protein virulence markers and pathogenicity of European S. suis strains was described in the literature (as discussed above). Like S. suis, the exact role of these extracellular and cell wall proteins in the pathogenesis of S. gallolyticus infections needs to be clarified. Nevertheless, in a study of prevalence, 94% of the strains lacking the A and T1 proteins were isolated from healthy pigeons, and only 6% were isolated from septicemia. Strains expressing A and/or T1, however, were isolated from septicemia in 57% of the cases. These observations may indicate that the A and/or T1 proteins are associated with virulence (266).
Vanrobaeys et al. (269) demonstrated that S. gallolyticus is an encapsulated organism and, that the capsule of the virulent strains had a regular, continuous appearance whilst irregularity of the capsule was a characteristic of the low virulence strains. Presence of fimbriae was also demonstrated in all strains belonging to the high virulence supernatant groups and in one strain of the moderately virulent group. The fimbriae are thin, flexible structures with a diameter of approximately 3-4 nm and a length of up to 700 nm. It was suggested that morphological differences in surface structure exist among virulent and low virulence pigeon S. gallolyticus strains, and that the capsule and/or fimbriae are possibly involved in virulence. In the Enterobacteriaceae, fimbriae serve as ligands during attachment to host cells. For the streptococci, the relationship between the presence of ultrastructural appendages and adhesion is less established. In pigeon S. gallolyticus strains, as well as all other streptococci, the role of fimbriae is not well known. In preliminary studies using pigeon, chicken, pig and sheep erythrocytes, pigeon S. gallolyticus strains were unable to cause hemagglutination (269) .
Finally, S. gallolyticus and S. bovis were shown to inhibit the growth of other streptococci. The antibacterial compounds produced by these bacteria are protease sensitive, remained active in a pH range from 1 to 12, and did not lose activity after heating at 100°C for 15 min. The antibacterial peptide (named as bovicin 255) was shown to have characteristics that are very similar to those described for class II bacteriocins of Gram-positive bacteria (270) . The diversity and density of the microbial population of the rumen suggest that this environment might favor the evolution of bacteriocins as competitive factors.
CONCLUDING REMARKS
The virulence of streptococci is considered as a multifactorial process. In contrast to well known human pathogens, and in spite of their veterinary importance, knowledge of virulence factors of several animal diseaseassociated streptococci is limited or almost inexistent. A common pattern for different streptococci seems to be the production of extracellular factors, such as capsule, hemolysins and other toxins, CAMP factor, M-like proteins and different proteases. Despite that these factors are present in many streptocci, their role in the pathogenesis of the respective infections is generally not known. In addition, as it is the case for S. pneumoniae, virulence factors usually present in strains of human origin are absent in those isolated from animals. For other streptococci, such as S. suis , it is still impossible to easily distinguish between virulent and non virulent strains. Further studies on virulence factors of different streptococci are granted. The genomic sequencing of members of streptococci associated with animal diseases, such as that of S. suis (http://www.sanger.ac.uk/Projects/S_suis/), as well as proteomic studies that will certainly follow, will probably clarify the pathogenesis of the infections caused by these important pathogens.
ACKNOWLEDGMENTS
We would like to thank Dr. Robert Higgins (Université de Montréal, Canada) for critical reviewing of this paper. Results on S. suis and S. agalactiae research carried out in our laboratory and briefly presented in this review have been funded by the Natural Science and Engineering Research Council of Canada and by the Canadian Network on Bacterial Pathogens of Swine. Lett 156, 161-164 (1997) 
